Examkin

Question

Difficulty: HardPediatric Neurologic Disorders

A 4-year-old boy is brought to the pediatric neurology clinic by his parents due to increasing unsteadiness. The parents report that although he started walking independently at 14 months of age, he has become progressively clumsy over the past year and now falls frequently. He has also had four episodes of prolonged cough and wheezing over the last eight months, which were treated with a short-acting bronchodilator with minimal improvement. Vital signs are within normal limits. Physical examination reveals a wide-based, unsteady gait and dysmetria on finger-to-nose testing. Close inspection of the eyes shows prominent networks of fine, red, dilated blood vessels on the bulbar conjunctivae. The patient's immunization record indicates he is due for his routine 4-year-old vaccinations, which include the measles, mumps, and rubella (MMR) vaccine and the varicella vaccine. Based on the most likely underlying diagnosis, which of the following is the most appropriate next step in management?

  1. A
    Administer all scheduled vaccinations to protect against severe pediatric viral illnesses
  2. B
    Initiate daily empiric broad-spectrum antibiotic prophylaxis to prevent further pulmonary complications
  3. Withhold the live-attenuated vaccines and obtain serum immunoglobulin levels and lymphocyte subsetsAnswer
  4. D
    Reassure the parents that the patient's gait findings are a normal variation of motor development
  5. E
    Prescribe daily inhaled corticosteroids for the management of underlying reactive airway disease

Answer

Withhold the live-attenuated vaccines and obtain serum immunoglobulin levels and lymphocyte subsets
The correct answer identifies the need to withhold live vaccines and perform an immunologic workup. The patient's presentation of progressive cerebellar ataxia, oculocutaneous telangiectasias, and recurrent sinopulmonary infections is the classic triad of Ataxia-Telangiectasia (A-T). A-T is an autosomal recessive disorder caused by a mutation in the ATM gene, which results in defective DNA repair. A major component of A-T is severe combined immunodeficiency, featuring decreased IgA, IgG, and IgE levels alongside significant T-cell lymphopenia and dysfunction. Due to the profound cellular immunodeficiency, live-attenuated vaccines (such as MMR and varicella) are strictly contraindicated because they can cause severe, uninhibited vaccine-strain infections. The appropriate action is to withhold these live vaccines and properly evaluate the extent of the immunologic deficit with serum immunoglobulins and lymphocyte subsets.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical triad presented in the vignette.
The combination of progressive cerebellar ataxia (wide-based gait, falls), oculocutaneous telangiectasias (red vessels on conjunctivae), and recurrent sinopulmonary infections (recurrent cough/wheezing) points to Ataxia-Telangiectasia (A-T).
Recognizing the syndrome is required to anticipate its systemic complications.
2
Recall the underlying pathophysiology and systemic manifestations of the diagnosed condition.
A-T is caused by an ATM gene mutation leading to defective DNA repair. It results in a severe combined immunodeficiency, typically involving deficiencies in IgA, IgG, IgE, and profound T-cell dysfunction.
Understanding the immune defect dictates the approach to routine preventative care.
3
Apply standard pediatric immunization contraindications to the patient's clinical status.
Live-attenuated vaccines, such as the MMR and varicella vaccines, are strictly contraindicated in patients with severe cellular (T-cell) immunodeficiencies due to the risk of fatal, vaccine-strain disseminated infection.
Patient safety relies on avoiding harmful interventions.
4
Determine the most appropriate clinical action.
The physician must withhold the MMR and varicella vaccines and order quantitative immunoglobulins and lymphocyte subsets to formally evaluate the immunodeficiency.
This establishes the severity of the immunodeficiency to guide future prophylactic therapies and definitively diagnoses the immune component of the disorder.

Key Concept

Patients with Ataxia-Telangiectasia have a severe cellular and humoral immunodeficiency, making live-attenuated vaccines strictly contraindicated.
Rate this question

Topics

Pediatric Neurologic Disorders

More questions from this topic